Pre-order Enquiry
Request Free Sample
Global Infectious Disease Biomarker Testing Market Size, Status and Forecast 2021-2027
SKU ID : QYR-19241954 | Publishing Date : 28-Sep-2021 | No. of pages : 117
Detailed TOC of Global Infectious Disease Biomarker Testing Market Size, Status and Forecast 2021-2027
1 Report Overview1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Infectious Disease Biomarker Testing Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 PCR
1.2.3 NGS
1.2.4 ELISA or EIA
1.2.5 IHC
1.2.6 ISH
1.2.7 Others
1.3 Market by Application
1.3.1 Global Infectious Disease Biomarker Testing Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals and Clinics
1.3.3 Diagnostic Centers
1.3.4 Academic Research Institutes
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Infectious Disease Biomarker Testing Market Perspective (2016-2027)
2.2 Infectious Disease Biomarker Testing Growth Trends by Regions
2.2.1 Infectious Disease Biomarker Testing Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Infectious Disease Biomarker Testing Historic Market Share by Regions (2016-2021)
2.2.3 Infectious Disease Biomarker Testing Forecasted Market Size by Regions (2022-2027)
2.3 Infectious Disease Biomarker Testing Industry Dynamic
2.3.1 Infectious Disease Biomarker Testing Market Trends
2.3.2 Infectious Disease Biomarker Testing Market Drivers
2.3.3 Infectious Disease Biomarker Testing Market Challenges
2.3.4 Infectious Disease Biomarker Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Infectious Disease Biomarker Testing Players by Revenue
3.1.1 Global Top Infectious Disease Biomarker Testing Players by Revenue (2016-2021)
3.1.2 Global Infectious Disease Biomarker Testing Revenue Market Share by Players (2016-2021)
3.2 Global Infectious Disease Biomarker Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Infectious Disease Biomarker Testing Revenue
3.4 Global Infectious Disease Biomarker Testing Market Concentration Ratio
3.4.1 Global Infectious Disease Biomarker Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Infectious Disease Biomarker Testing Revenue in 2020
3.5 Infectious Disease Biomarker Testing Key Players Head office and Area Served
3.6 Key Players Infectious Disease Biomarker Testing Product Solution and Service
3.7 Date of Enter into Infectious Disease Biomarker Testing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Infectious Disease Biomarker Testing Breakdown Data by Type
4.1 Global Infectious Disease Biomarker Testing Historic Market Size by Type (2016-2021)
4.2 Global Infectious Disease Biomarker Testing Forecasted Market Size by Type (2022-2027)
5 Infectious Disease Biomarker Testing Breakdown Data by Application
5.1 Global Infectious Disease Biomarker Testing Historic Market Size by Application (2016-2021)
5.2 Global Infectious Disease Biomarker Testing Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Infectious Disease Biomarker Testing Market Size (2016-2027)
6.2 North America Infectious Disease Biomarker Testing Market Size by Type
6.2.1 North America Infectious Disease Biomarker Testing Market Size by Type (2016-2021)
6.2.2 North America Infectious Disease Biomarker Testing Market Size by Type (2022-2027)
6.2.3 North America Infectious Disease Biomarker Testing Market Size by Type (2016-2027)
6.3 North America Infectious Disease Biomarker Testing Market Size by Application
6.3.1 North America Infectious Disease Biomarker Testing Market Size by Application (2016-2021)
6.3.2 North America Infectious Disease Biomarker Testing Market Size by Application (2022-2027)
6.3.3 North America Infectious Disease Biomarker Testing Market Size by Application (2016-2027)
6.4 North America Infectious Disease Biomarker Testing Market Size by Country
6.4.1 North America Infectious Disease Biomarker Testing Market Size by Country (2016-2021)
6.4.2 North America Infectious Disease Biomarker Testing Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Infectious Disease Biomarker Testing Market Size (2016-2027)
7.2 Europe Infectious Disease Biomarker Testing Market Size by Type
7.2.1 Europe Infectious Disease Biomarker Testing Market Size by Type (2016-2021)
7.2.2 Europe Infectious Disease Biomarker Testing Market Size by Type (2022-2027)
7.2.3 Europe Infectious Disease Biomarker Testing Market Size by Type (2016-2027)
7.3 Europe Infectious Disease Biomarker Testing Market Size by Application
7.3.1 Europe Infectious Disease Biomarker Testing Market Size by Application (2016-2021)
7.3.2 Europe Infectious Disease Biomarker Testing Market Size by Application (2022-2027)
7.3.3 Europe Infectious Disease Biomarker Testing Market Size by Application (2016-2027)
7.4 Europe Infectious Disease Biomarker Testing Market Size by Country
7.4.1 Europe Infectious Disease Biomarker Testing Market Size by Country (2016-2021)
7.4.2 Europe Infectious Disease Biomarker Testing Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Infectious Disease Biomarker Testing Market Size (2016-2027)
8.2 Asia-Pacific Infectious Disease Biomarker Testing Market Size by Type
8.2.1 Asia-Pacific Infectious Disease Biomarker Testing Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Infectious Disease Biomarker Testing Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Infectious Disease Biomarker Testing Market Size by Type (2016-2027)
8.3 Asia-Pacific Infectious Disease Biomarker Testing Market Size by Application
8.3.1 Asia-Pacific Infectious Disease Biomarker Testing Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Infectious Disease Biomarker Testing Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Infectious Disease Biomarker Testing Market Size by Application (2016-2027)
8.4 Asia-Pacific Infectious Disease Biomarker Testing Market Size by Region
8.4.1 Asia-Pacific Infectious Disease Biomarker Testing Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Infectious Disease Biomarker Testing Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Infectious Disease Biomarker Testing Market Size (2016-2027)
9.2 Latin America Infectious Disease Biomarker Testing Market Size by Type
9.2.1 Latin America Infectious Disease Biomarker Testing Market Size by Type (2016-2021)
9.2.2 Latin America Infectious Disease Biomarker Testing Market Size by Type (2022-2027)
9.2.3 Latin America Infectious Disease Biomarker Testing Market Size by Type (2016-2027)
9.3 Latin America Infectious Disease Biomarker Testing Market Size by Application
9.3.1 Latin America Infectious Disease Biomarker Testing Market Size by Application (2016-2021)
9.3.2 Latin America Infectious Disease Biomarker Testing Market Size by Application (2022-2027)
9.3.3 Latin America Infectious Disease Biomarker Testing Market Size by Application (2016-2027)
9.4 Latin America Infectious Disease Biomarker Testing Market Size by Country
9.4.1 Latin America Infectious Disease Biomarker Testing Market Size by Country (2016-2021)
9.4.2 Latin America Infectious Disease Biomarker Testing Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Infectious Disease Biomarker Testing Market Size (2016-2027)
10.2 Middle East & Africa Infectious Disease Biomarker Testing Market Size by Type
10.2.1 Middle East & Africa Infectious Disease Biomarker Testing Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Infectious Disease Biomarker Testing Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Infectious Disease Biomarker Testing Market Size by Type (2016-2027)
10.3 Middle East & Africa Infectious Disease Biomarker Testing Market Size by Application
10.3.1 Middle East & Africa Infectious Disease Biomarker Testing Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Infectious Disease Biomarker Testing Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Infectious Disease Biomarker Testing Market Size by Application (2016-2027)
10.4 Middle East & Africa Infectious Disease Biomarker Testing Market Size by Country
10.4.1 Middle East & Africa Infectious Disease Biomarker Testing Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Infectious Disease Biomarker Testing Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Abacus Diagnostica
11.1.1 Abacus Diagnostica Company Details
11.1.2 Abacus Diagnostica Business Overview
11.1.3 Abacus Diagnostica Infectious Disease Biomarker Testing Introduction
11.1.4 Abacus Diagnostica Revenue in Infectious Disease Biomarker Testing Business (2016-2021)
11.1.5 Abacus Diagnostica Recent Development
11.2 ALPCO
11.2.1 ALPCO Company Details
11.2.2 ALPCO Business Overview
11.2.3 ALPCO Infectious Disease Biomarker Testing Introduction
11.2.4 ALPCO Revenue in Infectious Disease Biomarker Testing Business (2016-2021)
11.2.5 ALPCO Recent Development
11.3 Abbott Laboratories
11.3.1 Abbott Laboratories Company Details
11.3.2 Abbott Laboratories Business Overview
11.3.3 Abbott Laboratories Infectious Disease Biomarker Testing Introduction
11.3.4 Abbott Laboratories Revenue in Infectious Disease Biomarker Testing Business (2016-2021)
11.3.5 Abbott Laboratories Recent Development
11.4 Agilent Technologies
11.4.1 Agilent Technologies Company Details
11.4.2 Agilent Technologies Business Overview
11.4.3 Agilent Technologies Infectious Disease Biomarker Testing Introduction
11.4.4 Agilent Technologies Revenue in Infectious Disease Biomarker Testing Business (2016-2021)
11.4.5 Agilent Technologies Recent Development
11.5 Becton
11.5.1 Becton Company Details
11.5.2 Becton Business Overview
11.5.3 Becton Infectious Disease Biomarker Testing Introduction
11.5.4 Becton Revenue in Infectious Disease Biomarker Testing Business (2016-2021)
11.5.5 Becton Recent Development
11.6 Dickinson and Company
11.6.1 Dickinson and Company Company Details
11.6.2 Dickinson and Company Business Overview
11.6.3 Dickinson and Company Infectious Disease Biomarker Testing Introduction
11.6.4 Dickinson and Company Revenue in Infectious Disease Biomarker Testing Business (2016-2021)
11.6.5 Dickinson and Company Recent Development
11.7 bioMérieux SA
11.7.1 bioMérieux SA Company Details
11.7.2 bioMérieux SA Business Overview
11.7.3 bioMérieux SA Infectious Disease Biomarker Testing Introduction
11.7.4 bioMérieux SA Revenue in Infectious Disease Biomarker Testing Business (2016-2021)
11.7.5 bioMérieux SA Recent Development
11.8 Bio-Rad Laboratories
11.8.1 Bio-Rad Laboratories Company Details
11.8.2 Bio-Rad Laboratories Business Overview
11.8.3 Bio-Rad Laboratories Infectious Disease Biomarker Testing Introduction
11.8.4 Bio-Rad Laboratories Revenue in Infectious Disease Biomarker Testing Business (2016-2021)
11.8.5 Bio-Rad Laboratories Recent Development
11.9 Danaher
11.9.1 Danaher Company Details
11.9.2 Danaher Business Overview
11.9.3 Danaher Infectious Disease Biomarker Testing Introduction
11.9.4 Danaher Revenue in Infectious Disease Biomarker Testing Business (2016-2021)
11.9.5 Danaher Recent Development
11.10 F. Hoffmann-La Roche
11.10.1 F. Hoffmann-La Roche Company Details
11.10.2 F. Hoffmann-La Roche Business Overview
11.10.3 F. Hoffmann-La Roche Infectious Disease Biomarker Testing Introduction
11.10.4 F. Hoffmann-La Roche Revenue in Infectious Disease Biomarker Testing Business (2016-2021)
11.10.5 F. Hoffmann-La Roche Recent Development
11.11 Hologic
11.11.1 Hologic Company Details
11.11.2 Hologic Business Overview
11.11.3 Hologic Infectious Disease Biomarker Testing Introduction
11.11.4 Hologic Revenue in Infectious Disease Biomarker Testing Business (2016-2021)
11.11.5 Hologic Recent Development
11.12 PerkinElmer
11.12.1 PerkinElmer Company Details
11.12.2 PerkinElmer Business Overview
11.12.3 PerkinElmer Infectious Disease Biomarker Testing Introduction
11.12.4 PerkinElmer Revenue in Infectious Disease Biomarker Testing Business (2016-2021)
11.12.5 PerkinElmer Recent Development
11.13 Qiagen
11.13.1 Qiagen Company Details
11.13.2 Qiagen Business Overview
11.13.3 Qiagen Infectious Disease Biomarker Testing Introduction
11.13.4 Qiagen Revenue in Infectious Disease Biomarker Testing Business (2016-2021)
11.13.5 Qiagen Recent Development
11.14 Quest Diagnostics Incorporated
11.14.1 Quest Diagnostics Incorporated Company Details
11.14.2 Quest Diagnostics Incorporated Business Overview
11.14.3 Quest Diagnostics Incorporated Infectious Disease Biomarker Testing Introduction
11.14.4 Quest Diagnostics Incorporated Revenue in Infectious Disease Biomarker Testing Business (2016-2021)
11.14.5 Quest Diagnostics Incorporated Recent Development
11.15 Siemens Healthineers
11.15.1 Siemens Healthineers Company Details
11.15.2 Siemens Healthineers Business Overview
11.15.3 Siemens Healthineers Infectious Disease Biomarker Testing Introduction
11.15.4 Siemens Healthineers Revenue in Infectious Disease Biomarker Testing Business (2016-2021)
11.15.5 Siemens Healthineers Recent Development
11.16 Thermo Fisher Scientific
11.16.1 Thermo Fisher Scientific Company Details
11.16.2 Thermo Fisher Scientific Business Overview
11.16.3 Thermo Fisher Scientific Infectious Disease Biomarker Testing Introduction
11.16.4 Thermo Fisher Scientific Revenue in Infectious Disease Biomarker Testing Business (2016-2021)
11.16.5 Thermo Fisher Scientific Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Figures, Tables and Charts Available in Global Infectious Disease Biomarker Testing Market Size, Status and Forecast 2021-2027
List of TablesTable 1. Global Infectious Disease Biomarker Testing Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of PCR
Table 3. Key Players of NGS
Table 4. Key Players of ELISA or EIA
Table 5. Key Players of IHC
Table 6. Key Players of ISH
Table 7. Key Players of Others
Table 8. Global Infectious Disease Biomarker Testing Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Infectious Disease Biomarker Testing Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 10. Global Infectious Disease Biomarker Testing Market Size by Regions (2016-2021) & (US$ Million)
Table 11. Global Infectious Disease Biomarker Testing Market Share by Regions (2016-2021)
Table 12. Global Infectious Disease Biomarker Testing Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 13. Global Infectious Disease Biomarker Testing Market Share by Regions (2022-2027)
Table 14. Infectious Disease Biomarker Testing Market Trends
Table 15. Infectious Disease Biomarker Testing Market Drivers
Table 16. Infectious Disease Biomarker Testing Market Challenges
Table 17. Infectious Disease Biomarker Testing Market Restraints
Table 18. Global Infectious Disease Biomarker Testing Revenue by Players (2016-2021) & (US$ Million)
Table 19. Global Infectious Disease Biomarker Testing Market Share by Players (2016-2021)
Table 20. Global Top Infectious Disease Biomarker Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Infectious Disease Biomarker Testing as of 2020)
Table 21. Ranking of Global Top Infectious Disease Biomarker Testing Companies by Revenue (US$ Million) in 2020
Table 22. Global 5 Largest Players Market Share by Infectious Disease Biomarker Testing Revenue (CR5 and HHI) & (2016-2021)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Infectious Disease Biomarker Testing Product Solution and Service
Table 25. Date of Enter into Infectious Disease Biomarker Testing Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Infectious Disease Biomarker Testing Market Size by Type (2016-2021) (US$ Million)
Table 28. Global Infectious Disease Biomarker Testing Revenue Market Share by Type (2016-2021)
Table 29. Global Infectious Disease Biomarker Testing Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 30. Global Infectious Disease Biomarker Testing Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 31. Global Infectious Disease Biomarker Testing Market Size Share by Application (2016-2021) & (US$ Million)
Table 32. Global Infectious Disease Biomarker Testing Revenue Market Share by Application (2016-2021)
Table 33. Global Infectious Disease Biomarker Testing Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 34. Global Infectious Disease Biomarker Testing Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 35. North America Infectious Disease Biomarker Testing Market Size by Type (2016-2021) (US$ Million)
Table 36. North America Infectious Disease Biomarker Testing Market Size by Type (2022-2027) & (US$ Million)
Table 37. North America Infectious Disease Biomarker Testing Market Size by Application (2016-2021) (US$ Million)
Table 38. North America Infectious Disease Biomarker Testing Market Size by Application (2022-2027) & (US$ Million)
Table 39. North America Infectious Disease Biomarker Testing Market Size by Country (2016-2021) & (US$ Million)
Table 40. North America Infectious Disease Biomarker Testing Market Size by Country (2022-2027) & (US$ Million)
Table 41. Europe Infectious Disease Biomarker Testing Market Size by Type (2016-2021) (US$ Million)
Table 42. Europe Infectious Disease Biomarker Testing Market Size by Type (2022-2027) & (US$ Million)
Table 43. Europe Infectious Disease Biomarker Testing Market Size by Application (2016-2021) (US$ Million)
Table 44. Europe Infectious Disease Biomarker Testing Market Size by Application (2022-2027) & (US$ Million)
Table 45. Europe Infectious Disease Biomarker Testing Market Size by Country (2016-2021) & (US$ Million)
Table 46. Europe Infectious Disease Biomarker Testing Market Size by Country (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Infectious Disease Biomarker Testing Market Size by Type (2016-2021) (US$ Million)
Table 48. Asia-Pacific Infectious Disease Biomarker Testing Market Size by Type (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Infectious Disease Biomarker Testing Market Size by Application (2016-2021) (US$ Million)
Table 50. Asia-Pacific Infectious Disease Biomarker Testing Market Size by Application (2022-2027) & (US$ Million)
Table 51. Asia-Pacific Infectious Disease Biomarker Testing Market Size by Region (2016-2021) & (US$ Million)
Table 52. Asia-Pacific Infectious Disease Biomarker Testing Market Size by Region (2022-2027) & (US$ Million)
Table 53. Latin America Infectious Disease Biomarker Testing Market Size by Type (2016-2021) (US$ Million)
Table 54. Latin America Infectious Disease Biomarker Testing Market Size by Type (2022-2027) & (US$ Million)
Table 55. Latin America Infectious Disease Biomarker Testing Market Size by Application (2016-2021) (US$ Million)
Table 56. Latin America Infectious Disease Biomarker Testing Market Size by Application (2022-2027) & (US$ Million)
Table 57. Latin America Infectious Disease Biomarker Testing Market Size by Country (2016-2021) & (US$ Million)
Table 58. Latin America Infectious Disease Biomarker Testing Market Size by Country (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Infectious Disease Biomarker Testing Market Size by Type (2016-2021) (US$ Million)
Table 60. Middle East & Africa Infectious Disease Biomarker Testing Market Size by Type (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Infectious Disease Biomarker Testing Market Size by Application (2016-2021) (US$ Million)
Table 62. Middle East & Africa Infectious Disease Biomarker Testing Market Size by Application (2022-2027) & (US$ Million)
Table 63. Middle East & Africa Infectious Disease Biomarker Testing Market Size by Country (2016-2021) & (US$ Million)
Table 64. Middle East & Africa Infectious Disease Biomarker Testing Market Size by Country (2022-2027) & (US$ Million)
Table 65. Abacus Diagnostica Company Details
Table 66. Abacus Diagnostica Business Overview
Table 67. Abacus Diagnostica Infectious Disease Biomarker Testing Product
Table 68. Abacus Diagnostica Revenue in Infectious Disease Biomarker Testing Business (2016-2021) & (US$ Million)
Table 69. Abacus Diagnostica Recent Development
Table 70. ALPCO Company Details
Table 71. ALPCO Business Overview
Table 72. ALPCO Infectious Disease Biomarker Testing Product
Table 73. ALPCO Revenue in Infectious Disease Biomarker Testing Business (2016-2021) & (US$ Million)
Table 74. ALPCO Recent Development
Table 75. Abbott Laboratories Company Details
Table 76. Abbott Laboratories Business Overview
Table 77. Abbott Laboratories Infectious Disease Biomarker Testing Product
Table 78. Abbott Laboratories Revenue in Infectious Disease Biomarker Testing Business (2016-2021) & (US$ Million)
Table 79. Abbott Laboratories Recent Development
Table 80. Agilent Technologies Company Details
Table 81. Agilent Technologies Business Overview
Table 82. Agilent Technologies Infectious Disease Biomarker Testing Product
Table 83. Agilent Technologies Revenue in Infectious Disease Biomarker Testing Business (2016-2021) & (US$ Million)
Table 84. Agilent Technologies Recent Development
Table 85. Becton Company Details
Table 86. Becton Business Overview
Table 87. Becton Infectious Disease Biomarker Testing Product
Table 88. Becton Revenue in Infectious Disease Biomarker Testing Business (2016-2021) & (US$ Million)
Table 89. Becton Recent Development
Table 90. Dickinson and Company Company Details
Table 91. Dickinson and Company Business Overview
Table 92. Dickinson and Company Infectious Disease Biomarker Testing Product
Table 93. Dickinson and Company Revenue in Infectious Disease Biomarker Testing Business (2016-2021) & (US$ Million)
Table 94. Dickinson and Company Recent Development
Table 95. bioMérieux SA Company Details
Table 96. bioMérieux SA Business Overview
Table 97. bioMérieux SA Infectious Disease Biomarker Testing Product
Table 98. bioMérieux SA Revenue in Infectious Disease Biomarker Testing Business (2016-2021) & (US$ Million)
Table 99. bioMérieux SA Recent Development
Table 100. Bio-Rad Laboratories Company Details
Table 101. Bio-Rad Laboratories Business Overview
Table 102. Bio-Rad Laboratories Revenue in Infectious Disease Biomarker Testing Business (2016-2021) & (US$ Million)
Table 103. Bio-Rad Laboratories Recent Development
Table 104. Danaher Company Details
Table 105. Danaher Business Overview
Table 106. Danaher Infectious Disease Biomarker Testing Product
Table 107. Danaher Revenue in Infectious Disease Biomarker Testing Business (2016-2021) & (US$ Million)
Table 108. Danaher Recent Development
Table 109. F. Hoffmann-La Roche Company Details
Table 110. F. Hoffmann-La Roche Business Overview
Table 111. F. Hoffmann-La Roche Infectious Disease Biomarker Testing Product
Table 112. F. Hoffmann-La Roche Revenue in Infectious Disease Biomarker Testing Business (2016-2021) & (US$ Million)
Table 113. F. Hoffmann-La Roche Recent Development
Table 114. Hologic Company Details
Table 115. Hologic Business Overview
Table 116. Hologic Infectious Disease Biomarker Testing Product
Table 117. Hologic Revenue in Infectious Disease Biomarker Testing Business (2016-2021) & (US$ Million)
Table 118. Hologic Recent Development
Table 119. PerkinElmer Company Details
Table 120. PerkinElmer Business Overview
Table 121. PerkinElmer Infectious Disease Biomarker Testing Product
Table 122. PerkinElmer Revenue in Infectious Disease Biomarker Testing Business (2016-2021) & (US$ Million)
Table 123. PerkinElmer Recent Development
Table 124. Qiagen Company Details
Table 125. Qiagen Business Overview
Table 126. Qiagen Infectious Disease Biomarker Testing Product
Table 127. Qiagen Revenue in Infectious Disease Biomarker Testing Business (2016-2021) & (US$ Million)
Table 128. Qiagen Recent Development
Table 129. Quest Diagnostics Incorporated Company Details
Table 130. Quest Diagnostics Incorporated Business Overview
Table 131. Quest Diagnostics Incorporated Infectious Disease Biomarker Testing Product
Table 132. Quest Diagnostics Incorporated Revenue in Infectious Disease Biomarker Testing Business (2016-2021) & (US$ Million)
Table 133. Quest Diagnostics Incorporated Recent Development
Table 134. Siemens Healthineers Company Details
Table 135. Siemens Healthineers Business Overview
Table 136. Siemens Healthineers Infectious Disease Biomarker Testing Product
Table 137. Siemens Healthineers Revenue in Infectious Disease Biomarker Testing Business (2016-2021) & (US$ Million)
Table 138. Siemens Healthineers Recent Development
Table 139. Thermo Fisher Scientific Company Details
Table 140. Thermo Fisher Scientific Business Overview
Table 141. Thermo Fisher Scientific Infectious Disease Biomarker Testing Product
Table 142. Thermo Fisher Scientific Revenue in Infectious Disease Biomarker Testing Business (2016-2021) & (US$ Million)
Table 143. Thermo Fisher Scientific Recent Development
Table 144. Research Programs/Design for This Report
Table 145. Key Data Information from Secondary Sources
Table 146. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Infectious Disease Biomarker Testing Market Share by Type: 2020 VS 2027
Figure 2. PCR Features
Figure 3. NGS Features
Figure 4. ELISA or EIA Features
Figure 5. IHC Features
Figure 6. ISH Features
Figure 7. Others Features
Figure 8. Global Infectious Disease Biomarker Testing Market Share by Application: 2020 VS 2027
Figure 9. Hospitals and Clinics Case Studies
Figure 10. Diagnostic Centers Case Studies
Figure 11. Academic Research Institutes Case Studies
Figure 12. Others Case Studies
Figure 13. Infectious Disease Biomarker Testing Report Years Considered
Figure 14. Global Infectious Disease Biomarker Testing Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 15. Global Infectious Disease Biomarker Testing Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 16. Global Infectious Disease Biomarker Testing Market Share by Regions: 2020 VS 2027
Figure 17. Global Infectious Disease Biomarker Testing Market Share by Regions (2022-2027)
Figure 18. Global Infectious Disease Biomarker Testing Market Share by Players in 2020
Figure 19. Global Top Infectious Disease Biomarker Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Infectious Disease Biomarker Testing as of 2020
Figure 20. The Top 10 and 5 Players Market Share by Infectious Disease Biomarker Testing Revenue in 2020
Figure 21. Global Infectious Disease Biomarker Testing Revenue Market Share by Type (2016-2021)
Figure 22. Global Infectious Disease Biomarker Testing Revenue Market Share by Type (2022-2027)
Figure 23. North America Infectious Disease Biomarker Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. North America Infectious Disease Biomarker Testing Market Share by Type (2016-2027)
Figure 25. North America Infectious Disease Biomarker Testing Market Share by Application (2016-2027)
Figure 26. North America Infectious Disease Biomarker Testing Market Share by Country (2016-2027)
Figure 27. United States Infectious Disease Biomarker Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Canada Infectious Disease Biomarker Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Europe Infectious Disease Biomarker Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Europe Infectious Disease Biomarker Testing Market Share by Type (2016-2027)
Figure 31. Europe Infectious Disease Biomarker Testing Market Share by Application (2016-2027)
Figure 32. Europe Infectious Disease Biomarker Testing Market Share by Country (2016-2027)
Figure 33. Germany Infectious Disease Biomarker Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. France Infectious Disease Biomarker Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. U.K. Infectious Disease Biomarker Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Italy Infectious Disease Biomarker Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Russia Infectious Disease Biomarker Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Nordic Infectious Disease Biomarker Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Asia-Pacific Infectious Disease Biomarker Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Asia-Pacific Infectious Disease Biomarker Testing Market Share by Type (2016-2027)
Figure 41. Asia-Pacific Infectious Disease Biomarker Testing Market Share by Application (2016-2027)
Figure 42. Asia-Pacific Infectious Disease Biomarker Testing Market Share by Region (2016-2027)
Figure 43. China Infectious Disease Biomarker Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Japan Infectious Disease Biomarker Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. South Korea Infectious Disease Biomarker Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Southeast Asia Infectious Disease Biomarker Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. India Infectious Disease Biomarker Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Australia Infectious Disease Biomarker Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Latin America Infectious Disease Biomarker Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Latin America Infectious Disease Biomarker Testing Market Share by Type (2016-2027)
Figure 51. Latin America Infectious Disease Biomarker Testing Market Share by Application (2016-2027)
Figure 52. Latin America Infectious Disease Biomarker Testing Market Share by Country (2016-2027)
Figure 53. Mexico Infectious Disease Biomarker Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Brazil Infectious Disease Biomarker Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Middle East & Africa Infectious Disease Biomarker Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Middle East & Africa Infectious Disease Biomarker Testing Market Share by Type (2016-2027)
Figure 57. Middle East & Africa Infectious Disease Biomarker Testing Market Share by Application (2016-2027)
Figure 58. Middle East & Africa Infectious Disease Biomarker Testing Market Share by Country (2016-2027)
Figure 59. Turkey Infectious Disease Biomarker Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Saudi Arabia Infectious Disease Biomarker Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. UAE Infectious Disease Biomarker Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 62. Abacus Diagnostica Revenue Growth Rate in Infectious Disease Biomarker Testing Business (2016-2021)
Figure 63. ALPCO Revenue Growth Rate in Infectious Disease Biomarker Testing Business (2016-2021)
Figure 64. Abbott Laboratories Revenue Growth Rate in Infectious Disease Biomarker Testing Business (2016-2021)
Figure 65. Agilent Technologies Revenue Growth Rate in Infectious Disease Biomarker Testing Business (2016-2021)
Figure 66. Becton Revenue Growth Rate in Infectious Disease Biomarker Testing Business (2016-2021)
Figure 67. Dickinson and Company Revenue Growth Rate in Infectious Disease Biomarker Testing Business (2016-2021)
Figure 68. bioMérieux SA Revenue Growth Rate in Infectious Disease Biomarker Testing Business (2016-2021)
Figure 69. Bio-Rad Laboratories Revenue Growth Rate in Infectious Disease Biomarker Testing Business (2016-2021)
Figure 70. Danaher Revenue Growth Rate in Infectious Disease Biomarker Testing Business (2016-2021)
Figure 71. F. Hoffmann-La Roche Revenue Growth Rate in Infectious Disease Biomarker Testing Business (2016-2021)
Figure 72. Hologic Revenue Growth Rate in Infectious Disease Biomarker Testing Business (2016-2021)
Figure 73. PerkinElmer Revenue Growth Rate in Infectious Disease Biomarker Testing Business (2016-2021)
Figure 74. Qiagen Revenue Growth Rate in Infectious Disease Biomarker Testing Business (2016-2021)
Figure 75. Quest Diagnostics Incorporated Revenue Growth Rate in Infectious Disease Biomarker Testing Business (2016-2021)
Figure 76. Siemens Healthineers Revenue Growth Rate in Infectious Disease Biomarker Testing Business (2016-2021)
Figure 77. Thermo Fisher Scientific Revenue Growth Rate in Infectious Disease Biomarker Testing Business (2016-2021)
Figure 78. Bottom-up and Top-down Approaches for This Report
Figure 79. Data Triangulation
Figure 80. Key Executives Interviewed
Keyplayers in Global Infectious Disease Biomarker Testing Market Size, Status and Forecast 2021-2027
Abacus DiagnosticaALPCO
Abbott Laboratories
Agilent Technologies
Becton
Dickinson and Company
bioMérieux SA
Bio-Rad Laboratories
Danaher
F. Hoffmann-La Roche
Hologic
PerkinElmer
Qiagen
Quest Diagnostics Incorporated
Siemens Healthineers
Thermo Fisher Scientific
Request Sample
Request Discount
